Creative Planning
IMNP

Creative Planning’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Creative Planning’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-250
Closed -$1K – 4412
2017
Q2 		$1K Sell
250
-350
-58% -$940 ﹤0.01% 4565
2017
Q1 		$2K Buy
600
+350
+140% +$1.26K ﹤0.01% 4377
2016
Q4 		$1K Buy
+250
New +$1.03K ﹤0.01% 4559
2016
Q2 		– Hold
0
– – – 4630
2016
Q1 		– Hold
0
– – – 4681
2015
Q4 		– Hold
0
– – – 4707
2015
Q3 		– Hold
0
– – – 4401
2015
Q2 		– Hold
0
– – – 3632
2015
Q1 		– Sell
-1
Closed -$37 – 4515
2014
Q4 		$0 Buy
+1
New +$54 ﹤0.01% 4453

Other funds holding IMNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Creative Planning's IMNP Position: Q3 2017 in Review

Creative Planning sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2017, closing a stake of 250 shares — an estimated $1K sold.

Creative Planning first reported a position in IMNP in Q4 2014 and held it in 4 quarters. The position peaked at $2K in Q1 2017. 12 funds tracked by Wall St. Rank hold IMNP as of Q3 2017.

  • Creative Planning reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 250 Immune Pharmaceuticals Inc. shares in Q3 2017, an estimated $1K.
  • Creative Planning first reported a position in Immune Pharmaceuticals Inc. in Q4 2014 and held it in 4 quarters.
  • Creative Planning's Immune Pharmaceuticals Inc. position peaked at $2K in Q1 2017.
  • 12 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.